Please provide your email address to receive an email when new articles are posted on . There was no link found between ever use of loop diuretics and changes in bone mineral density, falls and ...
Diuretics are agents commonly used in diseases characterized by excess extracellular fluid, including chronic kidney disease, the nephrotic syndrome, cirrhosis and heart failure. Multiple diuretic ...
Close to 6 million Americans live with heart failure, and each of their hospitalizations for the condition carries an average cost of $11,500, or $11 billion in total costs each year. Because no ...
In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...
Loop diuretics are commonly prescribed to older adults to induce diuresis in fluid-overload states, such as congestive heart failure, and to treat hypertension; however, these agents increase urinary ...
PRAGUE, Czechia—The number of people taking loop diuretics without a diagnosis of heart failure (HF) may be many times higher than the number of HF patients on these meds, according to an analysis of ...
Thirst outcomes were investigated among patients with stable heart failure (HF), due to the limited data available on this relationship and how it, along with fluid and sodium intake, influences ...
Study authors also assessed the relative risk of death at specific doses vs. no loop diuretic use and among specific loop diuretic doses. WASHINGTON, DC—An increased risk of mortality was seen with ...
Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...
The use of loop diuretics does not appear to be associated with changes in bone mineral density, falls or fractures in postmenopausal women, according to a report in the January 26 issue of Archives ...
A higher dose of loop diuretics was associated with more rapid skeletal muscle depletion and shorter survival in patients with liver cirrhosis, independent of the severity of disease, Japanese ...
LISBON — The diabetes and weight-loss drug semaglutide improves heart failure–related symptoms and physical limitations regardless of diuretic use in patients with obesity-related heart failure and ...